Call us today 212-583-0100

Investor Relations

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Jul 31, 2020

Company Overview

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

Investor Contact Information

Company

Enzo Biochem, Inc.
527 Madison Avenue
10022
New York, NY 10022
T: 212-583-0100

Investor Relations

IR@enzo.com

Transfer Agent

American Stock Transfer & Trust Company
T: 718-921-8380